Table 1 Detailed information of plasma cfDNA samples across different cancer types used in this study
Cohorts | Sample status | Sample number | Data source |
|---|---|---|---|
Li’s cohort |  | 332 | SRP080977 |
| Â | Gastric cancer(GC) | 62 | Â |
| Â | Benign gastric cancer | 22 | Â |
| Â | Colon cancer(CC) | 78 | Â |
| Â | Benign colon cancer | 49 | Â |
| Â | Hepatocellular carcinoma (HCC) | 25 | Â |
| Â | Healthy | 96 | Â |
Cai’s cohort |  | 2213 | SRP137706 |
| Â | Chronic hepatitis B virus infection (CHB) | 286 | Â |
| Â | Hepatocellular carcinoma (HCC) | 1251 | Â |
| Â | Liver cirrhosis | 106 | Â |
| Â | Healthy | 570 | Â |
Tian’s cohort |  | 333 | CRA000617 |
| Â | Esophageal cancer (EC) | 150 | Â |
| Â | Healthy | 183 | Â |
Zhang’s cohort |  | 133 | CRA000872 |
| Â | Non-small-cell lung cancer (NSCLC) | 66 | Â |
| Â | Healthy | 67 | Â |